CC241227C13000
- 0.00
- 0.000.00%
The Chemours Newsroom
Here's Buckley Capital's Updates on Chemours (CC)
Morgan Stanley Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $25
Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks Delivering High-Dividend Yields
Price Over Earnings Overview: Chemours
Worst Performing Stocks for Tax Loss Selling – Wolfe
Jefferies Maintains The Chemours(CC.US) With Hold Rating, Raises Target Price to $21
Express News | Chemours : Jefferies Raises Target Price to $21 From $20
Chemours Analyst Ratings
RBC Capital Maintains The Chemours(CC.US) With Buy Rating, Maintains Target Price $25
Does The Chemours Company (NYSE:CC) Create Value For Shareholders?
Olin Shares Sink as PCC Plans New Chlor-alkali Production at Chemours Plant
Express News | Pcc Group Plans to Build Chlor-Alkali Facility at Chemours Titanium Dioxide Plant in Delisle, MS Along the U.S. Gulf Coast
PCC Group Plans to Build Chlor-Alkali Facility at Chemours Titanium Dioxide Plant in DeLisle, MS Along the U.S. Gulf Coast
Wall Street's Most Accurate Analysts Spotlight On 3 Materials Stocks Delivering High-Dividend Yields
The Chemours Company (NYSE:CC) Is a Favorite Amongst Institutional Investors Who Own 83%
The Chemours Company Announces Completion of U.S. Dollar-denominated Term Loan Repricing
Express News | The Chemours Company Announces Completion of U.S. Dollar-Denominated Term Loan Repricing
The Chemours Company Announces Completion of Private Offering of $600,000,000 Aggregate Principal Amount of 8.000% Senior Unsecured Notes Due 2033
Chemours (NYSE:CC) Use Of Debt Could Be Considered Risky
(CC) - Analyzing Chemours's Short Interest